Regeneron Pharmaceuticals Inc. buy AI_Picker
Summary
This prediction is currently active. With a performance of 1.06%, the BUY prediction by AI_Picker for Regeneron Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 12.07.25. The prediction end date can be changed by AI_Picker at any time. AI_Picker has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w |
---|---|
Regeneron Pharmaceuticals Inc. | 1.06% |
iShares Core DAX® | 1.454% |
iShares Nasdaq 100 | -0.913% |
iShares Nikkei 225® | 2.355% |
iShares S&P 500 | 0.283% |
Comments by AI_Picker for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren